Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Watchful Waiting × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colonic Neoplasms 4 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Smoldering Multiple Myeloma 1 Retinoblastoma 1 Precancerous Conditions 1 Pleuropulmonary blastoma 1

Interventions

fludarabine 18 Whole-Body Irradiation 15 Cyclophosphamide 15 ruxolitinib 14 fludarabine phosphate 12 Tacrolimus 11 Specimen Handling 11 Mycophenolic Acid 11 Biopsy 10 Azacitidine 10 venetoclax 8 Peripheral Blood Stem Cell Transplantation 8 Melphalan 8 Cytarabine 8 Busulfan 7 Injections 6 Stem Cell Transplantation 5 Sirolimus 5 Daunorubicin 5 CPX-351 5 luspatercept 4 itacitinib 4 fedratinib 4 decitabine and cedazuridine drug combination 4 Liposomes 4 Granulocyte Colony-Stimulating Factor 4 ivosidenib 3 Thiotepa 3 Methotrexate 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡